Palliating advanced pancreatic cancer--in search of the Holy Grail
Krige, J.E.; Bornman, P.C.
South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie 39(3): 68-70; 73
2001
ISSN/ISBN: 0038-2361 PMID: 14601545 Document Number: 536951
Document emailed within 1 workday
Related Documents
Berendsen, H.J. 1998: A glimpse of the Holy Grail? Science 282(5389): 642-643Rahman, K.; Weber, T. 2003: Sustainable urban development in Brisbane City--the Holy Grail? Water Science and Technology: a Journal of the International Association on Water Pollution Research 47(7-8): 73-79
Fleischmann, R. 2002: In quest of the Holy Grail: efficacy versus effectiveness in rheumatoid arthritis Journal of rheumatology 29(9): 2018-9; author reply 2019
Cunningham, A.L.; Mikloska, Z. 2001: The Holy Grail: immune control of human herpes simplex virus infection and disease Herpes: the Journal of the Ihmf 8(Suppl 1): 6a
Canaud, B. 2004: Adequate dialysis, efficient dialysis: the "Holy Grail" of nephrology Nephrologie 25(3): 71-73
Nahum, Y. 2008: Advanced online search techniques and dedicated search engines for physicians Harefuah 147(2): 145-148; 182, 181
Berlin, J.D.; Rothenberg, M. 2001: Chemotherapy for resectable and advanced pancreatic cancer Oncology 15(10): 1241-1249; 1254; Discussion: 1254-1264
Czito, B.G.; Willett, C.G.; Clark, J.W.; Fernandez Del Castillo, C. 2000: Current perspectives on locally advanced pancreatic cancer Oncology 14(11): 1535-45; Discussion 1546 1549-52
Hayashi, K.; Uchida, K.; Hatori, T.; Takasaki, K. 2006: TS-1: S-1 based chemotherapy for far-advanced or relapsed pancreatic cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 1): 194-197
Ueno, H.; Okusaka, T. 2012: Systemic chemotherapy and chemoradiotherapy for advanced pancreatic cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(3): 357-363
Baba, H.; Suzuki, Y.; Ema, T.; Kawakami, M.; Nakanishi, C.; Hashimoto, T.; Arai, T.; Matsumoto, G.; Tsuruta, K.; Okamoto, A.; Karasawa, K. 2005: Gemcitabine concurrent with radiation for locally advanced pancreatic cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(11): 1730-1732
Choi, M.; Razzaque, S.; Kim, R. 2012: Systemic therapy of advanced pancreatic cancer: has the landscape changed? Clinical Advances in Hematology and Oncology: H&o 10(7): 442-451
Kurtz, J.E.; Kohser, F.; Négrier, S.; Trillet-Lenoir, V.; Walter, S.; Limacher, J.M.; Untereiner, M.; Kayitalire, L.; Jaeck, D.; Dufour, P. 2000: Gemcitabine and protracted 5-FU for advanced pancreatic cancer. A phase II study Hepato-Gastroenterology 47(35): 1450-1453
Stathopoulos, G.P.; Androulakis, N.; Souglakos, J.; Stathopoulos, J.; Georgoulias, V. 2008: Present treatment and future expectations in advanced pancreatic cancer Anticancer Research 28(2b): 1303-1308
Ohkawa, S. 2006: Gemcitabine chemotherapy for patients with advanced or relapsed pancreatic cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 1): 198-202
Sakata, Y.; Shimada, Y.; Yoshino, M.; Kambe, M.; Futatsuki, K.; Nakao, I.; Ogawa, N.; Wakui, A.; Taguchi, T. 1994: A late phase II study of CPT-11, irinotecan hydrochloride, in patients with advanced pancreatic cancer. CPT-11 Study Group on Gastrointestinal Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(7): 1039-1046
Kurtz, J-Emmanuel.; Négrier, S.; Husseini, F.; Limacher, J-Marc.; Borel, C.; Wagner, J-Philippe.; Prévot, G.; Bergerat, J-Pierre.; Dufour, P. 2003: A phase II study of docetaxel-irinotecan combination in advanced pancreatic cancer Hepato-Gastroenterology 50(50): 567-570
Tabchi, S.; Kourie, H.R.; Farhat, F.; Kattan, J. 2016: Early Increase of Ca 19-9 in Advanced Pancreatic Cancer Receiving Folfirinox. Is it a Sign of Efficacy? Le Journal Medical Libanais. Lebanese Medical Journal 64(2): 97-99
Taoka, H.; Hirano, H.; Mitsui, Y.; Umino, W.; Nobuoka, Y.; Yamashita, M.; Tanigawa, K.; Yoshimine, S.; Imai, T.; Kadowaki, S.; Miyashita, K.; Ikuma, H.; Nakamura, T.; Murata, T. 2004: Adjuvant chemotherapy for unresectable locally advanced pancreatic cancer in light of its characteristics Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(9): 1365-1370
Yajima, T.; Furukawa, Y.; Ishii, Y.; Hattori, Y.; Matsumoto, N.; Yamamoto, M.; Yamaoka, Y.; Fujihara, M.; Fujita, M.; Kuniki, H. 2004: Two cases of advanced pancreatic cancer responding to gemcitabine with long survival of 2 years Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(6): 953-957